ZA919296B - 2beta,19-ethylene bridged steroids as aromatase inhibitors - Google Patents

2beta,19-ethylene bridged steroids as aromatase inhibitors

Info

Publication number
ZA919296B
ZA919296B ZA919296A ZA919296A ZA919296B ZA 919296 B ZA919296 B ZA 919296B ZA 919296 A ZA919296 A ZA 919296A ZA 919296 A ZA919296 A ZA 919296A ZA 919296 B ZA919296 B ZA 919296B
Authority
ZA
South Africa
Prior art keywords
aromatase inhibitors
2beta
ethylene bridged
bridged steroids
steroids
Prior art date
Application number
ZA919296A
Other languages
English (en)
Inventor
John O'neal Johnston
O'neal Johnston John
Norton Paul Peet
Paul Peet Norton
Joseph Paul Burkhart
Paul Burkhart Joseph
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of ZA919296B publication Critical patent/ZA919296B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Bakery Products And Manufacturing Methods Therefor (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ZA919296A 1990-11-30 1991-11-25 2beta,19-ethylene bridged steroids as aromatase inhibitors ZA919296B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/621,184 US5166201A (en) 1990-11-30 1990-11-30 2β,19-ethylene bridged steroids as aromatase inhibitors

Publications (1)

Publication Number Publication Date
ZA919296B true ZA919296B (en) 1992-08-26

Family

ID=24489093

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA919296A ZA919296B (en) 1990-11-30 1991-11-25 2beta,19-ethylene bridged steroids as aromatase inhibitors

Country Status (20)

Country Link
US (1) US5166201A (ja)
EP (1) EP0488383B1 (ja)
JP (1) JP3143876B2 (ja)
KR (1) KR100190776B1 (ja)
CN (1) CN1033975C (ja)
AT (1) ATE142639T1 (ja)
AU (1) AU635444B2 (ja)
CA (1) CA2056638C (ja)
DE (1) DE69122048T2 (ja)
DK (1) DK0488383T3 (ja)
ES (1) ES2094183T3 (ja)
FI (1) FI102073B1 (ja)
GR (1) GR3021981T3 (ja)
HU (1) HU210830B (ja)
IE (1) IE914168A1 (ja)
IL (1) IL100196A (ja)
NO (1) NO180304C (ja)
NZ (1) NZ240738A (ja)
PT (1) PT99661B (ja)
ZA (1) ZA919296B (ja)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19510862A1 (de) * 1995-03-16 1996-09-19 Schering Ag Verwendung von Antiestrogenen zur männlichen Fertilitätskontrolle
ATE473759T1 (de) 1998-05-22 2010-07-15 Univ Leland Stanford Junior Bifunktionelle moleküle sowie darauf basierende therapien.
EP2392258B1 (en) 2005-04-28 2014-10-08 Proteus Digital Health, Inc. Pharma-informatics system
US9062126B2 (en) 2005-09-16 2015-06-23 Raptor Pharmaceuticals Inc. Compositions comprising receptor-associated protein (RAP) variants specific for CR-containing proteins and uses thereof
AU2010216512B2 (en) 2009-02-20 2016-06-30 2-Bbb Medicines B.V. Glutathione-based drug delivery system
WO2010129819A2 (en) 2009-05-06 2010-11-11 Laboratory Skin Care, Inc. Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3627756A (en) * 1970-04-23 1971-12-14 Searle & Co N-dialkylaminoalkyl-n-(2{62 ,19-epoxy-5{60 -androstan-17{62 -yl)amines/formamides and 3{60 -halo derivatives thereof
US4322416A (en) * 1980-06-27 1982-03-30 Merrell Dow Pharmaceuticals Inc. 10-Alkynyl steroids
GB8501035D0 (en) * 1985-01-16 1985-02-20 Senior J Prostaglandins
US4882322A (en) * 1988-10-27 1989-11-21 Merrell Dow Pharmaceuticals Inc. 3β,17β-hydroxy-substituted steroids and related steroidal compounds

Also Published As

Publication number Publication date
HU913739D0 (en) 1992-02-28
IL100196A0 (en) 1992-08-18
PT99661B (pt) 1999-05-31
KR100190776B1 (ko) 1999-06-01
NO180304B (no) 1996-12-16
NZ240738A (en) 1993-11-25
HU210830B (en) 1995-08-28
AU635444B2 (en) 1993-03-18
IL100196A (en) 1996-03-31
US5166201A (en) 1992-11-24
KR920009842A (ko) 1992-06-25
JP3143876B2 (ja) 2001-03-07
CN1061974A (zh) 1992-06-17
NO914710D0 (no) 1991-11-29
CN1033975C (zh) 1997-02-05
CA2056638C (en) 2002-03-05
NO914710L (no) 1992-06-01
FI102073B (fi) 1998-10-15
IE914168A1 (en) 1992-06-03
ATE142639T1 (de) 1996-09-15
PT99661A (pt) 1992-10-30
FI915623A0 (fi) 1991-11-28
HUT59937A (en) 1992-07-28
GR3021981T3 (en) 1997-03-31
FI915623A (fi) 1992-05-31
EP0488383A1 (en) 1992-06-03
ES2094183T3 (es) 1997-01-16
CA2056638A1 (en) 1992-05-31
EP0488383B1 (en) 1996-09-11
DK0488383T3 (da) 1996-09-30
DE69122048D1 (de) 1996-10-17
FI102073B1 (fi) 1998-10-15
DE69122048T2 (de) 1997-02-20
AU8812891A (en) 1992-06-04
JPH04290898A (ja) 1992-10-15
NO180304C (no) 1997-04-02

Similar Documents

Publication Publication Date Title
AU6972987A (en) Novel heterocyclic compounds
NO20002676D0 (no) Androgene steroidforbindelser og en fremgangsmÕte for fremstilling og anvendelse av samme
ZA919296B (en) 2beta,19-ethylene bridged steroids as aromatase inhibitors
TW336157B (en) Compositions and method for controlling harmful fungi
DE68911157D1 (de) Synthese von 6-Methylenandrosta-1,4-dien-3,17-dion-Derivate.
UA40574C2 (uk) Похідні 17,20-епоксипрегнану, спосіб їх одержання, спосіб одержання похідних кортизону і проміжні сполуки
DK0559706T3 (da) 2 beta,19-methylenamino-broforbundne steroider som aromataseinhibitorer.
HU9202100D0 (en) New 16-methyl-pregna-1,4-diene-3,20-dione derivatives
NZ237559A (en) Halogenoethyl steroid derivatives and pharmaceutical compositions
ES8604512A1 (es) Procedimiento para la obtencion de fenilhidrazonpirrolidinas substituidas
JPS52131580A (en) N-substituted pyridinium-2-sulfonylimines, containing same as active ingredient